Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Cost of Revenue (2018 - 2026)

Updated

Regenerative Medical Technology (RMTG) posted Cost of Revenue of $1.44 million for Q2 2026, up 263.2% from $397,686 a year earlier and up 65.5% from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Cost of Revenue (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Regenerative Medical Technology was $3.79 million, up 138.6% year-over-year; for FY2025, it was $2.29 million, up 78.3% from FY2024.

  • Annual Cost of Revenue has increased for five consecutive years, with a five-year compound annual growth rate of 120.5% (FY2020 to FY2025).
  • In prior years, Regenerative Medical Technology's Cost of Revenue was $1.28 million in FY2024 (+74.9%), $734,285 in FY2023 (+12.4%), $653,256 in FY2022 (+127.0%) and $287,750 in FY2021 (+554.7%).
  • The Q2 2026 figure stands as the highest quarterly Cost of Revenue in data going back to Q1 2018.
  • On a year-over-year basis, Cost of Revenue has increased in each of the last nine quarters, with growth averaging 117.2% over the last eight quarters.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q3 2021, with growth of 749.5%; the weakest was Q2 2023, with a decline of 28.6%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $872,862 (Q1 2026), $792,427 (Q4 2025) and $678,977 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 1.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.44 Mn
Mar 31, 2026 872,862.00
Dec 31, 2025 792,427.00
Sep 30, 2025 678,977.00
Jun 30, 2025 397,686.00
Mar 31, 2025 420,447.00
Dec 31, 2024 530,640.00
Sep 30, 2024 239,247.00
Jun 30, 2024 266,445.00
Mar 31, 2024 248,043.00
Dec 31, 2023 180,818.00
Sep 30, 2023 196,535.00
Jun 30, 2023 107,535.00
Mar 31, 2023 249,397.00
Dec 31, 2022 207,442.00
Sep 30, 2022 102,779.00
Jun 30, 2022 150,552.00
Mar 31, 2022 192,484.00
Dec 31, 2021 172,580.00
Sep 30, 2021 88,520.00
API Access

Regenerative Medical Technology Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RMTG&period=max&api_key=YOUR_API_KEY